Clinical outcome following late reperfusion with percutaneous coronary intervention in patients with ST-segment

Lars Nepper-Christensen1, Jacob Lønborg1, Dan Eik Høfsten1

  • 1Department of Cardiology, Copenhagen University Hospital, Denmark.

Insights

Patients with ST-elevation myocardial infarction (STEMI) experiencing delayed treatment beyond 12 hours show significantly worse outcomes. Early primary percutaneous coronary intervention is crucial for improving survival and reducing heart failure hospitalizations in STEMI patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • A significant proportion of ST-elevation myocardial infarction (STEMI) patients present for treatment more than 12 hours after symptom onset.
  • Clinical outcomes for STEMI patients receiving primary percutaneous coronary intervention (PCI) after a 12-hour delay remain understudied.

Purpose of the Study:

  • To investigate the association between delayed primary PCI (≥12 hours) and clinical outcomes in a contemporary STEMI cohort.
  • To evaluate the impact of late presentation on mortality and heart failure hospitalizations in STEMI patients.

Main Methods:

  • A large cohort of STEMI patients undergoing primary PCI in eastern Denmark (2009-2016) was analyzed.
  • Patients were stratified based on PCI timing: <12 hours versus ≥12 hours post-symptom onset.
  • The combined endpoint of all-cause mortality and heart failure hospitalization was tracked using nationwide registries.

Main Results:

  • 8% of 6674 STEMI patients received PCI ≥12 hours after symptom onset.
  • Long-term cumulative rates for the combined endpoint were higher in the late PCI group (37%) compared to the early PCI group (25%).
  • Late presentation (≥12 hours) was independently associated with a 42% increased risk of adverse clinical outcomes (HR 1.42, P<0.001).

Conclusions:

  • Delayed primary PCI in STEMI patients, particularly beyond 12 hours, is linked to poorer clinical outcomes.
  • Increasing the time from symptom onset to primary PCI correlates with a higher risk of adverse events.
  • Timely intervention remains critical for managing STEMI and improving patient prognosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
564
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
161
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
143
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
289